Nā helu waiwai kūʻai kūʻē i nā Milestones Lab: Heluhelu ʻia ʻo AI Peptide Rankings

Pane wikiwiki

E hoʻokaʻawale i ka pae hoʻokele peptide i alakaʻi ʻia e AI me nā KPI wet-lab. E aʻo i ke kumu o ka maʻemaʻe maʻemaʻe, nā kinetics hui, a me nā pūʻolo analytical mea nui mai ka pepa a i ke keʻena kino.

Nā helu waiwai kūʻai kūʻē i nā Milestones Lab: Heluhelu ʻia ʻo AI Peptide Rankings

Ua hoʻololi ka naʻauao artificial i ka loaʻa ʻana o ka lāʻau peptide mua. Hoʻopuka nā kumu hoʻohālike mīkini i mau kaukani mau kaʻina moʻolelo i kekona, ʻoiai ka helu helu helu algorithms e hoʻonohonoho i nā moho peptide e ka pili pili, hilinaʻi kūkulu, a me ka manaʻo o ka mākeke. No nā mea hoʻopukapuka kālā a me nā alakaʻi biopharma, Hāʻawi kēia mau helu hoʻopukapuka hoʻokele AI i kahi kiʻi hoʻowalewale o ka wikiwiki o ka pipeline a me ka ʻōlelo hoʻohiki.

Nā helu waiwai kūʻai kūʻē i nā Milestones Lab: Heluhelu ʻia ʻo AI Peptide Rankings

Eia naʻe, aia kekahi āwāwa pōʻino ma waena o nā helu helu helu a me ka ʻoiaʻiʻo benchtop. ʻO kahi moho e kū ana ma ka 99th percentile o kahi kumu hoʻohālike AI e hina pinepine i ka manawa i komo ai i loko o ke keʻena wai.. Hoʻoponopono nā algorithms i ke kūpono biological theoretical, akā mālama mau lākou i ka synthesis kemika, ka hoomaemae ana, a me ka hoʻonui ʻana i ka hana e like me nā pilikia i hoʻoholo ʻia. Ke neʻe nei mai ka pepa a i ke keʻena kino, ʻAʻole liʻiliʻi ka pili pili ʻana i ka manaʻo inā ʻaʻole hiki ke hana hou ʻia ke kaʻina ma ka nui..

No ke kūkulu ʻana i nā paipu hoʻomau, R&Pono nā hui D a me nā mea hoʻopukapuka kālā e nānā ma mua o nā helu helu helu a loiloi i nā peptides moho e kū'ē i nā milestones paʻakikī..

Nā helu waiwai kūʻai kūʻē i nā Milestones Lab: Heluhelu ʻia ʻo AI Peptide Rankings

ʻO ka wehe ʻana: No ke aha i hāʻule ʻole ai nā Peptides AI kiʻekiʻe ma ka Lab

Ke hilinaʻi nui nei nā algorithms ʻike lāʻau lāʻau AI o kēia manawa i nā metric wānana. ʻO nā mea hana e like me AlphaFold3 a me ESMFold e loiloi i nā moho me ka hoʻohana ʻana i ka interface i wānana ʻia i nā helu TM (ipTM) a wānana i nā hoʻokolohua ʻokoʻa mamao kūloko (pLDDT). ʻOiai ke wānana pololei nei kēia mau ana i ke ʻano o ka launa pū ʻana o kahi peptide me kahi mea hoʻokipa i hoʻopaʻa ʻia ma ka pale kamepiula, hana lākou i loko o kahi kaiaola kemika kūpono.

I loko o nā kŘkohu silico e loiloi i nā pilina pili pili, akā, haʻalele lākou i ka ʻoiaʻiʻo maoli o ka solid-phase peptide synthesis (SPSS) a me ka hana iho. Hiki i ke kŘkohu helu helu ke koho i ke ka'ina no ka pili pili loa ma ke kau 'ana i nā mea nui, hydrophobic, a i ʻole nā ​​waikawa amino kūlohelohe ma kahi kokoke. I ke kamepiula, ʻIke ʻia kēia mole me he therapeutic holomua. Ma ka peptide synthesizer, ʻo ia ke kumu o ka pilikia steric koʻikoʻi a me ka hoʻohui ʻana i waena o nā kaulahao, ʻo ka hopena o ka hāʻule ʻana o ka resin a me ka ʻole o ka hua ʻai.

Nā helu waiwai kūʻai kūʻē i nā Milestones Lab: Heluhelu ʻia ʻo AI Peptide Rankings

Ki Takeaway: Hōʻike nā helu helu helu kiʻekiʻe i ka ʻōlelo hoʻohiki biological theoretical, ʻaʻole hiki ke ola kemika. ʻAʻole waiwai ka moho peptide me ka pili ʻokoʻa ʻē aʻe inā hāʻule ka hua o ka synthesis ma lalo o nā paepae kūʻai..

Hoʻopaʻapaʻa pinepine nā pūʻulu helu helu ʻana i nā ʻano hoʻohālike o nā mīkini aʻo hou i nā kānana solubility a me nā mea wānana o ka hoʻolālā kiʻekiʻe. ʻOiai ʻoiaʻiʻo, wānana kēia mau algorithms i ka hana peptide i nā hoʻonā wai hoʻoheheʻe—ʻaʻole i ka wā o ka concentrated, ka honua hoʻoheheʻe-kaumaha o ka synthesis kemika a me ka hoʻomaʻemaʻe hoʻomākaukau. Pono ka unuhi ʻana i ka ʻōlelo hoʻopukapuka kālā i loko o ka Chemistry, Hana ʻana, a me na Mana (CMC) anana.

Nā helu waiwai kūʻai kūʻē i nā Milestones Lab: Heluhelu ʻia ʻo AI Peptide Rankings

ʻO ka 5 ʻIke ʻole ʻia nā KPI kālā i nā kumu hoʻohālike kālā

Ke nānā aku nei nā hiʻohiʻona helu kālā i ka mākeke hiki ke hoʻopili ʻia (TAM), helu patent, a me ka hana olaola wanana. No ka loiloi inā hiki i kahi moho peptide ke ola i ka unuhi lapaʻau, R&Pono nā hui D e nānā i nā KPI ʻelima lab-centric i ʻike ʻole ʻia e nā kumu hoʻohālike kālā.

1. ʻO ka hoʻomaʻemaʻe maʻemaʻe a me ka hoʻomaʻemaʻe kino

Hoʻopili nā kumu hoʻohālikelike AI i nā hōʻike synthesis kiʻekiʻe, akā ʻaʻole hiki iā lākou ke nānā i nā kiʻi chromatographic crude. ʻO ka maʻemaʻe maʻemaʻe e ana i ka hapa o ka peptide i loaʻa ma hope koke o ka wehe ʻana mai ka resin, ma mua o ka hoʻomaʻemaʻe ʻana.

Ke hāʻawi mai kahi kaʻina paʻakikī i ka maʻemaʻe maʻemaʻe wale nō 45% i 50%, ka hoʻomākaukau ʻana i ka chromatography wai hana kiʻekiʻe (RP-HPLC) ke alo i kahi kaua piʻi. Ka hoʻokaʻawale ʻana i ka peptide i hoʻopaʻa ʻia mai nā kaʻina hoʻopau pili pili (n-1 a me n-2 haumia), nā ʻāpana ʻoki ʻia, a me nā diastereomers i hana ʻia e ka racemization waikawa amino pono e hoʻomaʻemaʻe multi-pass. ʻO kēlā me kēia pā chromatographic hou e hōʻemi nui i ka hoʻihoʻi ʻana i ke kaʻina hana, ka hoʻohuli ʻana i ka moho hoʻomaʻemaʻe haʻahaʻa i mea hoʻokele waiwai.

Manaʻo nā luna hoʻoponopono i ka mana ikaika ma luna o kēia mau haumia synthetic. Wahi a Nā kikoʻī ICH Q6B no ka maʻemaʻe olaola (2025), pono nā mea hoʻomohala e hoʻokumu i nā kikoʻī kikoʻī no ka ʻike, ka maemae, a me ka hoʻopaʻa ʻana o ka puʻupuʻu. ʻO kahi kumu hoʻohālike kālā e loiloi wale ana i ka maʻemaʻe o ka huahana hope loa e nānā ʻole i ka nui o ka pohō i koi ʻia e hōʻea i kēlā kikoʻī mai kahi hui lepo lepo..

2. Hana Hana a Hoʻohui Kinetics

Ke hilinaʻi nei ka synthesis peptide solid-phase i nā hopena hoʻohui pū ʻana o ka amino acid ma ke kākoʻo polymeric insoluble.. ʻO ka maikaʻi o kēlā me kēia ʻanuʻu hui e kuhikuhi i ka holomua a i ʻole ka hāʻule ʻana o kahi synthesis.

Hoʻomaka pinepine nā pilina hydrophobic pili i ke kaʻina i ka hōʻuluʻulu pepa beta ma luna o ka resin synthesis. Ke hiki mai ka hui, ʻo ke kaulahao peptide e ulu nei e pelu hou ana iā ia iho, e ālai kino ana i nā ʻakika amino e hiki mai ana mai ka hiki ʻana i ka N-terminus reactive.

Kākoʻo Solid-Phase → Hydrophobic Sequence → Beta-Sheet Inter-Chain Aggregation → Steric Blockade o N-Terminus

ʻO ka lanakila ʻana i nā kinetics hoʻohui maikaʻi ʻole e koi i nā hana kemika pipiʻi, e like me ka hoʻokomo ʻana i nā pseudoproline dipeptides, me ka hoʻohana ʻana i nā hui pale kuamoʻo kūikawā, a i ʻole ka hoʻohana ʻana i ka hoʻomehana microwave-kōkua. ʻAʻole hopu nā kumu hoʻohālike kālā i kēia mau koina hana. Hiki i kahi hoʻohālike AI ke hoʻolālā i kahi peptide 35-mer nani, akā, inā pono kēlā me kēia kolu o ka hoʻohui ʻana i nā reagents kūikawā a me nā pōʻai hoʻololi hoʻonui, ʻO ke kumukūʻai o ka hana ʻana e pōlele wikiwiki i ka wā o ka hoʻomohala ʻana.

ʻIke ʻia ʻo Benchtop Case Insight: Ma kahi loiloi ʻoihana hou o kahi moho therapeutic 32-mer i hana ʻia e AI, ua wānana nā kumu hoʻohālikelike i ka pili ʻokoʻa ($ipTM > 0.88$) a me ke kūpaʻa hoʻonā maikaʻi. Eia naʻe, i ka wā maʻamau SPPS automated, he kaʻina hydrophobic e kau ana ma waena o nā koena 14 a 22 ua hoʻoulu ʻia ka hōʻuluʻulu waena waena ma ka resin. Ua hāʻule ka maʻemaʻe maʻemaʻe mua i ka pono 28%, ka hoʻomākaukau ʻana i ka hoʻokaʻawale ʻana o ka HPLC me ka hiki ʻole ke ola a hiki i ka hana hou ʻana o ka synthesis protocol me nā pseudoproline dipeptides..

3. Hoʻololi Paʻakikī a me Regiospecific Chemistry

No ka hoʻomaikaʻi ʻana i ke kūpaʻa metabolic a me ka hapalua ola o ka plasma, ʻO nā lāʻau lapaʻau peptide hou e pili ana i nā hoʻololi kemika paʻakikī. Loaʻa kēia mau alahaka cyclic disulfide, ka hui ʻana o ka diacid lipid no ka hoʻopaʻa albumin, nā hōʻailona fluorescent, a me ka hoʻokomo ʻana i ka amino acid kūlohelohe.

Nānā nā kumu hoʻohālike kālā i nā hoʻololi e like me nā hiʻohiʻona hoʻohui waiwai e hoʻonui ai i ka waiwai naʻauao a me ka pono therapeutic. I ka hale hana, akā naʻe, ʻO kēlā me kēia hoʻololi e hoʻokomo i ka pilikia exponential. ʻo kahi laʻana, ʻO nā peptides i loaʻa i ʻehā a ʻoi aʻe nā koena cysteine ​​e hiki ke hana i nā isomers i hoʻopaʻa ʻia disulfide hewa ʻole i ka wā o ka pelu ʻana o ka oxidative.. ʻO ke kuhikuhi ʻana i ka mole i loko o kāna hoʻohālikelike ʻōiwi ponoʻī e pono ai nā ʻōnaehana pale orthogonal multi-step (e like me ka hui pū ʻana iā Trt, Acm, a me nā hui mālama Mob).

Peptide Unfolded (4 Cys) → Oxidation Kūikaʻi ʻole → Nā Isomers Disulfide Kūlike ʻole (Holoi ʻāwili)

Peptide Unfolded (4 Cys) → Palekana Orthogonal (Trt/Acm) → Pepa Kūʻokoʻa → Isomer Bioactive Native

ʻO kēlā me kēia hana pale a me ka deprotection e hōʻemi ana i ka hua kemika holoʻokoʻa. ʻO ka hoʻomohala ʻana i kahi kaʻina hana scalable no kahi peptide i hoʻololi ʻekolu ʻia e koi i ka hoʻonui ʻana i ka hopena i hiki ʻole i nā algorithms kālā ke wānana..

4. Nā Pūʻolo Analytical a me ka Hohonu Hōʻike

Nīnau pinepine nā mea hoʻopukapuka inā ua hoʻopuka kahi CDMO i kahi palapala hōʻoia no ka ʻikepili (KoA) hōʻoia i ka maʻemaʻe o ka huahana. Eia naʻe, ʻO kahi pākēneka maʻemaʻe hoʻokahi ma kahi pepa CoA hāʻawi i ka hōʻoia liʻiliʻi o ka mākaukau hoʻoponopono.

Pono nā waihona hoʻoponopono i kahi pūʻolo kikoʻī analytical piha. Wahi a ka Nā alakaʻi ʻepekema EMA e pili ana i ka hoʻomohala ʻana i ka peptide synthetic (2022), Pono nā mea hoʻomohala e hōʻoia i ka ʻike a me ka maʻemaʻe me ka hoʻohana ʻana i nā ʻenehana analytical orthogonal. Aia kēia me ka High-Resolution Electrospray Ionization Mass Spectrometry (ESI-MS) e hōʻoia i ka nui monoisotopic, RP-HPLC ka lōʻihi nalu ʻelua, helu kūʻē, ke koena o ka solvent screening (acetonitrile, dimethylformamide, piperidine), a me ka ho'āʻo microbial.

⚠️ ʻŌlelo Aʻo: Hōʻike ʻia kahi palapala hōʻoia o ka loiloi maʻamau 98% maʻemaʻe e UV absorbance ma 220 ʻaʻole lawa ka nm no ka waiho ʻana i ke kauka. Me ka ʻole o ka ESI-MS orthogonal a me ka helu counterion, i ʻike ʻole ʻia nā mea haumia co-eluting a i ʻole koena trifluoroacetic acid (TFA) hiki ke hoʻololi i nā haʻawina holoholona preclinical.

ʻO ka hoʻokele Counterion kahi analytical analytical koʻikoʻi i poina nā kumu hoʻohālike kālā. Hoʻokaʻawale ʻia nā peptides synthetic e like me trifluoroacetate (TFA) nā paʻakai. No ka mea, he mea ʻawaʻawa ʻo TFA i nā pūnana mammalian, Pono nā moho lāʻau lapaʻau e hoʻololi i ka counterion exchange i nā ʻano acetate a i ʻole chloride. ʻAʻole hiki ke nānā a hōʻoia i ka hoʻololi counterion (<1% TFA koena) hiki ke alakaʻi i ka ʻawaʻawa nui o ka cell i ka wā o ka screening preclinical, hōʻailona wahaheʻe i ka hiki ʻole o ka lāʻau lapaʻau.

5. ʻO ka Scalability kaʻina hana a me ka ikaika nui o ka hana (PMI)

ʻO ka hoʻololi ʻana mai ka nānā ʻana i ka milligram-scale i loko o nā keʻena noiʻi i ka kilo-kilo-kilo cGMP hana lapaʻau e hōʻike ana i ka pilikia nui loa i ka hoʻomohala ʻana i ka lāʻau peptide..

Nā protocol Synthesis e hana maʻalahi i ka 10 ʻAʻole pinepine ka mg synthesizer automated ke hoʻonui ʻia i 500 pūʻulu gram i nā mea kanu hoʻokele. Hoʻopau ka SPPS nui i ka nui o nā solvents organik. Ka noiʻi i paʻi ʻia ma ka ACS Journal of Organic Chemistry ma Kaʻina Hana Nui (PMI) ana ma SPPS (2024) hōʻike i ka hana ʻana 1 kg o synthetic peptide API hoʻopuka i ka awelika o 13,000 kg o ka ʻōpala kemika.

1 kg Peptide API Hana ʻia → 13,000 kg ʻO ka ʻōpala hoʻoheheʻe i hana ʻia (PMI ≈ 13,000)

Ke hoʻonui nei ka nui o nā pūʻulu, ʻai hoʻoheheʻe, hiki ke kolamu HPLC hoʻomākaukau, a me ka maloʻo maloʻo (lyophilization) lilo nā manawa i mau bottlenecks hana nui. ʻO kahi algorithm helu helu helu e loiloi ana i kahi peptide ma kahi kaʻawale ka nānā ʻana inā loaʻa i kahi hale hana ke ʻano kolamu a me ka hiki ke hoʻomaʻemaʻe e hoʻoponopono i nā pūʻulu kilokilo me ka ʻole o ka ua a me ka hoʻohaʻahaʻa..


Puhi hana: Ka unuhi ʻana i ka ʻōlelo a ka mea hoʻopukapuka i loko o nā mea hana mua

E kōkua iā R&Hoʻopili nā hui D a me nā alakaʻi biotech i ka ʻokoʻa ma waena o nā helu helu helu a me nā mea hana maoli, ʻO kēia kaʻina hana pono e hoʻohālikelike ai i nā metric waiwai AI me kā lākou mau hoa keʻena hana maoli.

Mea hoʻopukapuka AI Metric He aha ia ana KPI Keʻena Hana ʻike ʻole Hana R&D Manao
ʻO ka pilina i wānana ʻia ($pKd / ipTM$) Ka ikaika hoʻopaʻa ʻana i ka helu ʻana i ka mea hoʻokipa Maʻemaʻe Maʻemaʻe & Hāʻawi Hoʻoponopono i nā chromatogram maʻemaʻe mua; e hōʻoia ua ʻoi aku ka nui o ka hua 60% ma mua o ka laka kepau.
Helu Mea Hou Uniqueness o kemika wahi no ka IP pale Hoʻohui Kinetics E nānā i nā kumu hydrophobic aggregation-prone; e nānā i ka pono o nā kōkua pseudoproline.
Helu Hoololi Pahuhi Ka helu o nā pūʻulu hana (lipids, nā hōʻailona, nā pōʻaiapuni) Peʻi ʻana & Hāʻawi i ka poho E loiloi i nā papa hana pale orthogonal; e helu i ka huina kumulative yield ma nā hoʻololi.
Pepa Pipeline Velocity ʻO ka wikiwiki mai ka hoʻolālā kaʻina a hiki i ke koho ʻana i nā moho Hōhonu Pūʻolo Analytical Koi i ka orthogonal High-Res ESI-MS, koena hoʻāʻo solvent, a me ka ʻikepili hoʻololi counterion.
Makeke Waiwai Nui Manaʻo ʻia ʻo TAM a me ka hiki ke hoʻihoʻi ʻoihana Kaʻina Hana Nui (PMI) Hōʻike i ka hoʻonui waiwai mai ka mg a i ke kilo; hōʻoia i ka hiki ke hoʻoheheʻe CDMO a me nā palena kolamu.

No ke kōkua: Ma mua o ka laka ʻana i kahi kaʻina peptide alakaʻi e pili ana i nā kumu hoʻohālike AI, e kauoha i ka hui hookolokolo (10 mg i 50 mg) mai kahi CDMO akamai. E koi i ka mea kūʻai aku e hoʻolako maka, nā chromatograms RP-HPLC i hoʻoponopono ʻole ʻia i ana ʻia ma 214 nm, Nā hōʻike kikoʻī ESI-MS, a me ka ʻikepili hua ʻai.


Hoʻopaʻa i ka ʻAha: Ka hui pū ʻana me Specialized Peptide Synthesis CDMOs

ʻO ka hoʻololi ʻana i kahi moho peptide i hoʻolālā ʻia e AI mai ka helu helu helu ʻana i ka ʻoiaʻiʻo o ka lāʻau lapaʻau e pono ai ka hui pū ʻana ma waena o nā mea olaola computational a me bench chemists.. ʻOiai ʻoi aku ka maikaʻi o nā paepae AI i ka hana kuhiakau wikiwiki, ʻO ka hōʻoia ʻana i kēlā mau hale manaʻo e koi i nā ʻenehana loea kūikawā, empirical reaction optimization, a me ka hoʻomalu maikaʻi analytical.

No ka hoʻēmi ʻana i ka pilikia o ka unuhi ʻana i ka wā mua, R&Hōʻoia pinepine nā hui D i ka hana ʻana ma o ka holo pilote empirical. Ke komo ʻana a scalable maʻamau peptide synthesis platform hiki i nā mea noiʻi ke loiloi i ka hoʻohui ʻana i nā kinetics a me ka maʻemaʻe maʻemaʻe ma nā unahi milligram ma mua o ka hana ʻana i ke kālā nui i ka hana pilot-scale..

No nā kaʻina hoʻololi paʻakikī-e like me ka lipidated GLP-1 receptor agonists a i ʻole nā ​​hale hoʻolālā multi-cyclic-ʻo ka kūleʻa e pili ana i nā hoʻolālā pale regiospecific a me ka ʻike loea post-synthetic.. Ka hui pū ʻana me nā mea hoʻolako kūikawā hāʻawi peptide CRO a me nā lawelawe hoʻololi e hōʻoia i ka hoʻonohonoho pono ʻana o nā ʻōnaehana pale orthogonal a me nā protocol folding oxidative no ka hoʻōla kiʻekiʻe..

ʻO ka hope loa, ʻO ka hoʻololi ʻana i nā moho i ka loiloi lapaʻau e koi i nā mana kaiapuni ikaika. Ka hoʻopili ʻana, ka hoomaemae ana, a me ka lyophilization i loko Papa 100 nā lumi hoʻomaʻemaʻe ultra-sterile hāʻawi i ka hōʻoia hoʻoponopono koʻikoʻi, ka mālama ʻana i nā paepae endotoxin ultra-haʻahaʻa a me ka hoʻokō piha ʻana i ka sterility (USP <71>/<85>) ma nā pae hoʻomohala āpau.


Nīnau pinepine

No ke aha e hāʻule pinepine ai nā peptides AI kiʻekiʻe i ka wā o ka peptide synthesis solid-phase?

Hoʻohālikelike nā kumu hoʻohālike AI i ka hoʻopaʻa ʻana i ka manaʻo a me nā hoʻolālā hoʻonā. ʻAʻole lākou e noʻonoʻo i nā mechanics synthesis solid-phase, kahi i hoʻohui ʻia ai nā motif kaʻina hydrophobic ma waena o nā kaulahao beta-sheet aggregation ma ka resin. Hoʻopili kēia hui ʻana i ka N-termini reactive, e alakaʻi ana i ka maʻemaʻe haʻahaʻa haʻahaʻa a me ka hoʻopili piha ʻole.

Pehea ka hoʻomaʻemaʻe ʻana o ka peptide crude i nā kumukūʻai hana?

Hōʻike ka maʻemaʻe maʻemaʻe i ka hapa o ka peptide i hoʻopaʻa ʻia ma hope koke o ka wehe ʻana o ka resin. Inā he haʻahaʻa ka maʻemaʻe maʻemaʻe (<50%), ʻO ka hoʻokaʻawale ʻana i ka peptide i hoʻopaʻa ʻia e koi i nā ala he nui ma nā kolamu RP-HPLC hoʻomākaukau. ʻO kēlā me kēia palapala hoʻomaʻemaʻe ke kumu o ka pohō pūhui nui, e hoʻonui i ka hoʻohana ʻana i ka solvent, manawa hana, a me ka huina kālā API.

He aha nā hoʻāʻo analytical e koi ʻia ma mua o kahi palapala hōʻoia kumu?

Pono nā ʻano hoʻāʻo orthogonal i kahi pūʻolo analytical regulatory piha. Hoʻopili kēia i ka High-Resolution ESI-MS no ka hōʻoia ʻana i ka nui o ka monoisotopic, RP-HPLC ma 214 nm, ke koena o ka solvent screening, TFA-a-acetate counterion quantification (<1% TFA), a me USP <71> sterility a me ka USP <85> hōʻoia endotoxin.

He aha ka Process Mass Intensity (PMI) a no ke aha he mea nui ia no ka peptide scale-up?

ʻO ka Process Mass Intensity e ana i ka huina nui o nā kemika a me nā mea hoʻoheheʻe i hoʻohana ʻia no ka hana ʻana i kahi hui nui o ka API lāʻau hope loa.. He PMI kiʻekiʻe loa ko SPPS (ʻawelika 13,000 kg solvent per 1 kg peptide API). He mea koʻikoʻi ka hoʻokele ʻana i ka PMI i ka wā e hoʻonui ai i ka nui o ka noiʻi milligram a hiki i ka kilokani i nā pahu lāʻau lapaʻau e pale ai i nā bottlenecks hiki ke kolamu a me nā kumukūʻai hoʻomau ʻole..


Nā ʻanuʻu aʻe no R&D Nā Hui

Inā ke loiloi nei kāu hui i nā moho peptide i hoʻolālā ʻia e AI a i ʻole e hoʻomākaukau ana i kahi pipeline computational no CDMO handoff, e hoʻokumu i kahi loiloi hana maʻamau ma mua o ke koho alakaʻi. E noʻonoʻo i nā ʻaoʻao hoʻopaʻa ʻia ʻana, koi ʻia ka hoʻāʻo analytical orthogonal, a hui pū me nā hui hana ʻike i ka wā mua e hōʻoia i kāu holomua helu helu e hoʻokō i ka holomua lapaʻau.

Xiaoxia Chen

Xiaoxia Chen

Laau Laau Hou R&D ʻenehana Kaʻike kumu: Loaʻa ka pahuhopu, pilina hana-hana (SAR) kālailai, peptide-lāʻau conjugates (Nā PDC), a me ka hoʻomohala ʻana i nā peptides anti-kahiko a me ka metabolic.

Pilikino: Ua alakaʻi ʻo Xiaoxia Chen i ka ʻike mua ʻana a me ka noiʻi preclinical no kekahi mau lāʻau peptide metabolic a me ka tumor-targeted.. ʻAʻole wale ʻo ia i mākaukau i ka nānā ʻana i nā hale waihona puke peptide, akā akamai nō hoʻi i ka hoʻohana ʻana i ka biology computational kōkua AI no ka hoʻolālā ʻana o ka de novo peptide sequence.. I kēia manawa, ke alakaʻi nei ʻo ia i kahi hui i hoʻolaʻa ʻia i ka noiʻi hohonu a me ka hoʻomohala ʻana o nā agonists multifunctional hanauna hou (like me pālua- a i ʻole nā ​​peptides hoʻohaʻahaʻa momona ʻekolu) a me nā peptides hoʻoponopono hou i ke kino.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana